Release Notice - Canadian Cancer Statistics: A 2020 special report on lung cancer.
出版信息
Health Promot Chronic Dis Prev Can. 2020 Sep;40(9):325. doi: 10.24095/hpcdp.40.10.05.
Abstract
摘要
相似文献
1
Release Notice - Canadian Cancer Statistics: A 2020 special report on lung cancer.发布通知 - 加拿大癌症统计数据：2020年肺癌特别报告。
Health Promot Chronic Dis Prev Can. 2020 Sep;40(9):325. doi: 10.24095/hpcdp.40.10.05.
2
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.采用风险模型进行肺癌筛查的研究对象选择（泛加拿大肺癌早期检测[PanCan]研究）：一项单臂前瞻性研究。
Lancet Oncol. 2017 Nov;18(11):1523-1531. doi: 10.1016/S1470-2045(17)30597-1. Epub 2017 Oct 18.
3
Performance of the cancer risk management model lung cancer screening module.肺癌筛查模块的癌症风险管理模型性能。
Health Rep. 2015 May;26(5):11-8.
4
5
Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012.2012 年 USPSTF 发布 D 级前列腺特异性抗原筛查建议后，按阶段、NCCN 风险分组和年龄划分的前列腺癌发病率。
Cancer. 2020 Feb 15;126(4):717-724. doi: 10.1002/cncr.32604. Epub 2019 Dec 3.
6
Screening for lung cancer: A systematic review and meta-analysis.肺癌筛查：一项系统评价与荟萃分析。
Prev Med. 2016 Aug;89:301-314. doi: 10.1016/j.ypmed.2016.04.015. Epub 2016 Apr 26.
7
Screening for lung cancer.肺癌筛查
Br J Hosp Med (Lond). 2015 Jun;76(6):C89-93. doi: 10.12968/hmed.2015.76.6.C89.
8
The development of staging data for use in the microsimulation of lung cancer.
Health Rep. 1992;4(3):251-68.
9
Implementation of Lung Cancer Screening in the Veterans Health Administration.在退伍军人健康管理局实施肺癌筛查。
JAMA Intern Med. 2017 Mar 1;177(3):399-406. doi: 10.1001/jamainternmed.2016.9022.
10
Screening for lung cancer.肺癌筛查
Am Fam Physician. 2014 Jul 15;90(2):117-8.
引用本文的文献
1
Ex vivo use of probe-based confocal laser endomicroscopy in lung cancer visualization: an ex vivo pilot study.基于探头的共聚焦激光内镜术在肺癌可视化中的体外应用：一项体外初步研究。
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):163-171. doi: 10.47162/RJME.66.1.15.
2
Tumor microenvironment in squamous cell lung cancer - histological and immunohistochemical study.肺鳞状细胞癌的肿瘤微环境——组织学和免疫组织化学研究
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):153-161. doi: 10.47162/RJME.66.1.14.
3
Development and validation of a prognostic nomogram for bone metastasis from lung cancer: A large population-based study.肺癌骨转移预后列线图的开发与验证：一项基于大人群的研究。
Front Oncol. 2022 Sep 30;12:1005668. doi: 10.3389/fonc.2022.1005668. eCollection 2022.
4
Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution.单机构早期非小细胞肺癌立体定向体部放射治疗的结果
Cureus. 2022 Feb 3;14(2):e21878. doi: 10.7759/cureus.21878. eCollection 2022 Feb.
5
An Audit of Opportunistic Lung Cancer Screening in a Canadian Province.加拿大某省机会性肺癌筛查审计。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211051484. doi: 10.1177/21501327211051484.
6
Regional Delivery of Anti-PD-1 Agent for Colorectal Liver Metastases Improves Therapeutic Index and Anti-Tumor Activity.用于结直肠癌肝转移的抗程序性死亡蛋白1（PD-1）药物区域给药可提高治疗指数和抗肿瘤活性。
Vaccines (Basel). 2021 Jul 21;9(8):807. doi: 10.3390/vaccines9080807.
Zotero 插件